Serrhel Adams, MD
Retina Specialist · Springdale, ARNPI 1366474538
Payments from drug & device makers
Across 158 payments — averaging $1558.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$168K
- Genentech USA, Inc.$44K
- AbbVie$14K
- Regeneron$10K
- Eyepoint US, Inc.$7K
- Astellas Pharma US Inc$2K
- plus $1K from 13 others
What the payments were for
- Consulting fees$9,29019%
- Speaking & faculty fees$34,39072%
- Travel & lodging$9342%
- Food & beverage$3,4417%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 29 | $167,724 |
| Genentech USA, Inc. | 45 | $44,117 |
| AbbVie(2 entities) | 14 | $14,105 |
| Regeneron | 2 | $9,855 |
| Eyepoint US, Inc. | 3 | $6,932 |
| Astellas Pharma US Inc | 7 | $2,125 |
| Regeneron Healthcare Solutions, Inc. | 15 | $303 |
| Alcon | 4 | $272 |
| Boston Scientific | 10 | $175 |
| Biogen | 8 | $173 |
| Apellis Pharmaceuticals, Inc. | 7 | $143 |
| Novartis | 7 | $116 |
| Carl Zeiss Meditec USA, Inc. | 1 | $96 |
| Coherus Oncology, Inc. | 1 | $34 |
| Sandoz | 1 | $28 |
| Amgen | 1 | $23 |
| Alimera Sciences, Inc. | 1 | $22 |
| Dutch Ophthalmic, USA | 1 | $22 |
| Carl Zeiss Meditec, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few retina specialist providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 91 | $2,319 |
| Difluprednate | 11 | $1,384 |
| Brimonidine Tartrate | 99 | $659 |
| Acetazolamide | 65 | $248 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 11 | $27 |
| Diazepam | 25 | $4 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Springdale
- Alice KennedyConway$80K
- John DellacroceFayetteville$39K
- Cedric PrattLittle Rock$11K
- Bradley HughesLittle Rock$4K
- Stephen DavisLittle Rock$3K
- John KingLittle Rock$3K
- Gerald WareLittle Rock$3K
- Muhammad ShamimLittle Rock$2K
- Paul HrubyLittle Rock$1K
- Pedro Soibelmann TetelbomLittle Rock$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.